Leonard John M

President and CEO, DirectorIntellia Therapeutics, Inc. (NTLA) · full profile →Form 4 · filed Dec 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$836K
Net Open-Market Flow
-$836K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Option exercise(M)9K$6.83$58K1.0M
Dec 11, 2025Sell(S)5K$9.59$51K1.0M
Dec 11, 2025Option exercise(M)50K$6.83$341K1.1M
Dec 11, 2025Sell(S)50K$9.49$474K1.1M
Dec 11, 2025Sell(S)33K$9.47$311K1.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2025Option exercise(M)9K$00
Dec 11, 2025Option exercise(M)50K$09K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-317551) within minutes of acceptance. Every field above traces to the original document. Verify it directly: